BioTech Mag Search: Therapies
Astellas Bets On Gene Therapy With $3B Audentes Acquisition Offer
9 days ago - By Xconomy
Japanese drug giant Astellas Pharma announced late Monday it has agreed to buy Audentes Therapeutics, which is developing gene therapies for rare neuromuscular diseases. It's an all-cash deal worth $3 billion, with the Astellas offer of $60 per share representing a 110 percent premium to Audentes' share price of $28.61 apiece at market close Monday. The agreement is the latest big bet by a major pharmaceutical company on gene therapy, which aims to provide long-lasting, if not permanent, disease treatments. San Francisco-based Audentes' lead drug candidate, AT132, is a clinical-stage...
Read more ...Astellas inks $3B Audentes buyout to expand in gene therapy
9 days ago - By Fierce Biotech
Astellas Pharma is set to buy Audentes Therapeutics for $3 billion. The deal will enable Astellas to set up a new genetic regulation unit spearheaded by a neuromuscular disease gene therapy that is set to be submitted for approval next year.
Read more ...
Search by Tags
Therapies Pharmaceutical Pharma Therapeutics Drugs Drug Pharmaceuticals Clinical Gene Genes Gene Therapy National National blog main National top stories San Francisco blog main San Francisco top stories Acquisition Antitrust Astellas Pharma Audentes Big Pharma Biotech Buyout Clinical trials Deals Drug Pricing FDA Joseph Schwartz Life Sciences M&A Mergers Neuromuscular disease Orbimed Rare disease Regulatory review Roche Spark Spark Therapeutics Startup SVB Leerink Genetics
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
MiRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal
MicroRNA therapies developer miRagen Therapeutics is scaling back work on its most advanced cancer drug candidate and shifting resources to a compound being developed to treat...
Tiny Quantum Sensors Watch Materials Transform Under Pressure
At left, natural diamonds glow under ultraviolet light owing to their various nitrogen-vacancy centers. At right, a schematic depicting the diamond anvils in action, with NV...
Simulations Attempt to Reconstruct One of the Most Explosive Events in the...
Artist's illustration of two merging neutron stars. The rippling space-time grid represents gravitational waves that travel out from the collision, while the narrow beams show...
Amgen's Osteoporosis Drug Wins European Nod, With a Heart Warning
An osteoporosis drug developed by Amgen now has marketing approval in Europe, but it carries a warning that the medicine can raise the risk of cardiovascular problems...
Aspen Neuro Bags $6.5M to Test Parkinson's Disease Stem Cell Therapy
Nearly nine years ago Jeanne Loring and her colleagues at Scripps Research debuted a test that leveraged advances in genomics and data science to determine, without testing in...
How Thermo Fisher Scientific Streamlined Inspection Management With AuditUtopia®
Case Study Overview In highly regulated industries, you can count on the fact that your company will be inspected a time or two by regulatory agencies and/or your clients. Most...
Cover Picture: Biotechnology Journal 12/2019
Microbial poly‐3‐hydroxybutyrate has been produced via microbial fermentation and safely used as feed additives for sea based large yellow croakers and sensitive land based...
Iterum's Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink
Iterum Therapeutics' bid to bring patients a new antibiotic that's safer than currently available drugs has fallen short of the main efficacy goal of a late-stage clinical...
A Peek into the Battery Technology Pipeline
Berkeley Lab battery researcher Gerbrand Ceder Lithium ion is probably the most advanced technology available for the packs of rechargeable batteries you'll buy this holiday...
Long-Read Sequencing Could Improve the Sensitivity and Precision of 16S...
It's time to revisit the way scientists are using 16S rRNA gene sequencing to study microorganisms, according to a team of Jackson Laboratory researchers. Popular targets for...